Akshay Vaishnaw, MD, PhDPresident at Alnylam Pharmaceuticals
Dr. Akshay Vaishnaw joined Alnylam Pharmaceuticals in 2006 as VP Clinical Research and has then subsequently served in various R&D roles with increasing responsibility. Akshay was promoted to President of R&D in March of 2018 and was appointed as President of Alnylam in January of 2022. Prior to 2006, he was at Biogen as Senior Director, Translational Medicine.
Akshay received his M.D. from the University of Wales College of Medicine, U.K., and Ph.D. from the University of London, U.K., in Molecular Immunology. He is a Fellow of the Royal College of Physicians, U.K. Akshay is a member of the Board of Directors for Editas Medicine Inc. and Scholar Rock Inc. From 2014-2018, he served as a Board member of Visterra, Inc.